• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Regardless of political party, Americans overwhelmingly support Medicare drug price negotiations

Bioengineer by Bioengineer
August 28, 2023
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

SAN DIEGO — August 28, 2023 — As the pharmaceutical industry ramps up efforts to fight the U.S. government’s historic Medicare Drug Price Negotiation Program, a new West Health-Gallup public opinion survey shows overwhelming bipartisan support for the program, which is forecast to save $100 billion in its first decade.

83% of Americans Support Medicare Drug Price Negotiations

Credit: West Health

SAN DIEGO — August 28, 2023 — As the pharmaceutical industry ramps up efforts to fight the U.S. government’s historic Medicare Drug Price Negotiation Program, a new West Health-Gallup public opinion survey shows overwhelming bipartisan support for the program, which is forecast to save $100 billion in its first decade.

“No matter who they vote for, Americans are suffering from the high costs of prescription drugs,” says Tim Lash, president of West Health, a family of nonprofit organizations focused on reducing healthcare costs and improving quality of care. “The public’s overwhelming support for this policy, even as we head into a presidential election, makes one thing exceedingly clear: people know unfair, anticompetitive behavior when they see it and they want it to stop.”

This week, the Centers for Medicare & Medicaid Services (CMS) will publish the first 10 Medicare drugs selected for the Medicare Drug Price Negotiation Program, with revised prices taking effect January 2026. CMS will then select up to 15 more drugs for 2027, 15 more drugs for 2028, and 20 more drugs for each year after that, as outlined in the Inflation Reduction Act.

But pharmaceutical companies are seeking to block the program through lawsuits and other means, despite broad and enduring public support for Medicare’s ability to negotiate lower prices for the nation’s more-than 65 million Medicare enrollees.

The new West Health-Gallup survey shows 83% of Americans favor price negotiations between Medicare and pharmaceutical companies, including 95% of Democrats, 76% of Independents and 75% of Republicans. Similar levels of support were consistent across age, race, gender, income levels and education.        

Dramatic savings are expected from the program. The Congressional Budget Office estimates negotiations directly between Medicare and drug makers could reduce spending by $3.7 billion in its first year and save more than $100 billion over the next decade. But even more importantly, it could save lives. According to a report prepared by research arm of drug distributor AmerisourceBergen for West Health, 112,000 seniors could die prematurely each year because drug prices and associated costs are so high that they can’t afford their medication.

“Big Pharma’s high drug prices are killing us, fueling a public health and humanitarian crisis of its own,” Lash says. “Giving Medicare the power to negotiate is an important step, but we can’t lose sight of the fact that more reforms are needed. Anti-competitive behavior in healthcare is a burden for everyone, regardless of their politics.”

About the West Health-Gallup Survey

The new public opinion survey on Medicare drug-price negotiations was carried out between May 30 and June 6 by Gallup in partnership with West Health. Gallup surveyed 2,145 adults living in all 50 U.S. states and the District of Columbia, All samples are weighted to correct for unequal selection probability and non-response. Post-stratification weighting takes into account gender, age, race, Hispanic ethnicity, education and region. Demographic weighting targets are based on the most recent Current Population Survey figures. The survey carries a margin of error at the 95% confidence level is +2.7 percentage points for response percentages around 50% and is +1.6 percentage points for response percentages around 10% or 90%, design effect included. For reported sub-groups, the margin of error will be larger, typically ranging from ±3.5 to ±6 percentage points.

About West Health

Solely funded by philanthropists Gary and Mary West, West Health is a family of nonprofit and nonpartisan organizations including the Gary and Mary West Foundation and Gary and Mary West Health Institute in San Diego, and the Gary and Mary West Health Policy Center in Washington, D.C. West Health is dedicated to lowering healthcare costs to enable seniors to successfully age with access to high-quality, affordable health and support services that preserve and protect their dignity, quality of life and independence. Learn more at westhealth.org.



Share12Tweet8Share2ShareShareShare2

Related Posts

Generative AI Reveals Hidden Bird Flu Exposure Risks in Maryland Emergency Departments

Generative AI Reveals Hidden Bird Flu Exposure Risks in Maryland Emergency Departments

August 25, 2025

Innovative Technique Investigates Cancer Cell Messengers That Suppress the Immune System

August 25, 2025

Insurance Status in Asian American Cancer Patients

August 25, 2025

Caspar David Friedrich: Perspectives on Aging and Longevity

August 25, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    145 shares
    Share 58 Tweet 36
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Generative AI Reveals Hidden Bird Flu Exposure Risks in Maryland Emergency Departments

Innovative Technique Investigates Cancer Cell Messengers That Suppress the Immune System

Insurance Status in Asian American Cancer Patients

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.